Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-052221

EVP, Research & CSO acquired 3,700 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Virgin Herbert · EVP, Research & CSO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-09-24 Exercise or conversion : show line 1 in the form +3,700 $1.53 $5,661 23,700 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-09-24 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −3,700 463,385 D
Loading xslF345X03/doc4.xml…